Real-world experience with eculizumab in Japanese patients with myasthenia gravis: Post-marketing surveillance data

被引：0
|
作者：
Takahashi, M. [1 ]
Masuda, M. [2 ]
Watanabe, M. [3 ]
Fukamizu, Y. [4 ]
Osawa, T. [4 ]
Kikui, H. [4 ]
Murai, H. [5 ]
机构：
[1] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan
[2] Tokyo Med Univ, Dept Neurol, Tokyo, Japan
[3] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol, Fukuoka, Japan
[4] Alex Pharma GK, AstraZeneca Rare Dis, Tokyo, Japan
[5] Int Univ Hlth & Welf, Dept Neurol, Narita, Japan
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-396
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [41] Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance
    Kato, Chihiro
    Yoshisue, Hajime
    Nakamura, Noriko
    Sasajima, Takayoshi
    INTERNAL MEDICINE, 2022, 61 (06) : 789 - 800
  • [42] EXPLORING THE PATH TO DIAGNOSIS FOR PATIENTS WITH MYASTHENIA GRAVIS USING REAL-WORLD DATA
    Tierney, M.
    Chen, J.
    Snell, Taylor S.
    Cibelli, E.
    VALUE IN HEALTH, 2023, 26 (06) : S255 - S256
  • [43] Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study
    Nozawa, Yumiko
    Kato, Daisuke
    Tabuchi, Hiromi
    Kuroishi, Kentarou
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (02) : 122 - 130
  • [44] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    NEUROLOGY, 2022, 98 (18)
  • [45] A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients
    Pane, Chiara
    Di Stefano, Vincenzo
    Cuomo, Nunzia
    Sarnataro, Alessio
    Vinciguerra, Claudia
    Bevilacqua, Liliana
    Brighina, Filippo
    Rini, Nicasio
    Puorro, Giorgia
    Marsili, Angela
    Garibaldi, Matteo
    Fionda, Laura
    Sacca, Francesco
    JOURNAL OF NEUROLOGY, 2024, 271 (09) : 6209 - 6219
  • [46] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
    Sacca, F.
    Cuomo, N.
    Russo, C.
    Campanile, M.
    Puorro, G.
    Marsili, A.
    Pane, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 569
  • [47] Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data
    Fan, Qianqian
    Hu, Yang
    Yang, Changqing
    Zhao, Bin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 76
  • [48] Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance data
    Qin, Wangjun
    Zhao, Bin
    Shang, Yongguang
    Zhang, Lei
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (09) : 1109 - 1115
  • [49] A REAL-WORLD DATA APPROACH TO ADVANCE RESEARCH IN MYASTHENIA GRAVIS
    Lopez, Lauren N.
    Nichols, Caitlin
    Cotter, Kristina
    MUSCLE & NERVE, 2022, 65 : S36 - S36
  • [50] Clinical outcomes with daptomycin: a post-marketing, real-world evaluation
    Sakoulas, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 11 - 16
12345